Api Concern: Cefixime Market Share Will Continue To Grow

The next few years, Cephalosporin Cefixime market share will continue to grow, but Cefixime API The price of raw materials prices by the major impact on the whole, the price was down trend.

According to Traditional Chinese Medicine Economic News on June 12 reported cases of clinical drug monitoring, in recent years, as oral Antibiotic The clinical cefixime dosage has been an upward trend. And now Cefixime has a mature industrial process line, still in the market introduction phase, with more than a second-generation cephalosporin higher profits. These factors make cefixime to cephalosporin products from a number of stand out.

Cefixime Fujisawa Pharmaceutical Industries, Ltd. of Japan developed the third generation product, in 1987 in Japan.

China in 1994 and began importing raw materials and preparation of cefixime, the earliest use of imported raw materials preparation pharmaceutical enterprises in Guangdong Baiyun Mountain. Cefixime granules of raw materials and the application of administrative protection in China in early 2001 due, but because of its clinical effect is obvious, the precise effects and side effects, therefore, its market demand in recent years has been in a rapid increase in the channel.

As a third generation oral products, the clinical application of cefixime has been widely recognized, agents demand growth year by year, especially in the sales performed well in 2007, resulting in the "small cephalosporin" stand out: 2007 hospitals in the sample sales reached 13,940 million, up over 100% growth rate; the next few years, cefixime will continue to grow market share.

As cefixime has a promising, no doubt attracted many enterprises have joined, making the area the more intense competition. Increased production enterprises, coupled with import brands to carve up the market, making the field of cefixime is also facing a lot of pressure.

2008 years, the market cefixime in bulk drugs into the competitive stage, the number of production enterprises, but as of May 2008, with cefixime approval of raw material drug production as many as 23 companies, agents enterprises approval even more numerous. As the competition for the "cake" by many - in addition to domestic manufacturers, as well as imported products and national products in the competition for the market, thus causing a certain degree of raw materials cefixime drug prices plummeted.

Domestic product manufacturers cefixime main pharmaceutical factory in Guangzhou Baiyun Mountain, the founding Pharmaceutical Co., Ltd., Guangdong, Shandong Lukang Pharmaceutical (600,789 market, stock it) Co., Ltd. and Chongqing Traditional Chinese Medicine Co., Ltd. Suzhou million. These large enterprises are to cephalosporin products for the main business, which Baiyunshan Pharmaceutical and Shandong Lukang are produced downstream of cefixime preparation. According to statistics, the domestic annual production of cefixime of about 100 tons, of which the output of the largest pharmaceutical Baiyun Mountain, the main downstream agent is consumed in large quantities, therefore, the basic APIs are for personal use.

View of cefixime attractive "gold content", recently there have been manufacturers increased the production of cefixime input. Qi Luan for Pharmaceutical Co., Ltd. is planning to expand its market size cefixime; State Pharmaceutical Co., Ltd. Zhejiang Provincetown may produce 60 tons of cefixime are undergoing environmental assessment of production lines; There are other smaller production companies such as Zhejiang Yongning pharmaceutical, pharmaceutical and other Heze Rui Ying, also brewing in the operation of the market cefixime. The next period of time, the price war seems inevitable; Although the market has formed a basic pattern, but the yield of small businesses are still cause for concern.

Cefixime drug prices of raw materials also rose ups and downs all the way down, and under great influence on the upstream raw material prices. Overall, their prices were declining trend.

2006 in the second half, prices have continued to penicillin industrial salt, or 30%, triggering a domestic GCLE and cefixime drug prices of raw materials; At the same time, the international market, sales are cefixime increase. Therefore, the second half of 2007, in the upstream raw material prices have come down as well as increased domestic production GCLE driven by the domestic price of cefixime dropped to about 3,000 yuan / kg.

About The Author I am an expert from China Crafts Suppliers, usually analyzes all kind of industries situation, such as earth auger drill , gas powered winches.